Literature DB >> 10635560

Structural conversion from non-native to native form of recombinant human epidermal growth factor by Brevibacillus choshinensis.

A Miyauchi1, M Ozawa, M Mizukami, K Yashiro, S Ebisu, T Tojo, T Fujii, H Takagi.   

Abstract

Brevibacillus choshinensis (Bacillus brevis) HPD31 is a very efficient producer of recombinant human epidermal growth factor (EGF). The produced EGF is secreted into the medium with high efficiency. However part of the EGF that accumulates in the medium, exists as multimeric forms which are biologically inactive. We found the bacterium has the activity to structurally convert multimeric forms to the monomeric, native ones. Optimal temperature and pH for the conversion were 40 degrees C and pH 9, respectively. The reaction was promoted in the presence of reduced glutathione or cysteine. But the cells which had been sonicated or exposed to moderate heat treatment completely lost the activity. Thus, it was presumed that the activity might be due to the enzyme(s) that catalyze the protein disulfide exchanging reaction, and that they resides on the surface of viable cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10635560     DOI: 10.1271/bbb.63.1965

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  4 in total

1.  Comprehensive study of domain rearrangements of single-chain bispecific antibodies to determine the best combination of configurations and microbial host cells.

Authors:  Ryutaro Asano; Yuri Kuroki; Sachiko Honma; Mihoko Akabane; Shunsuke Watanabe; Shinzo Mayuzumi; Shuichi Hiyamuta; Izumi Kumagai; Koji Sode
Journal:  MAbs       Date:  2018-07-09       Impact factor: 5.857

2.  Nasal vaccination with the 40-kilodalton outer membrane protein of Porphyromonas gingivalis and a nontoxic chimeric enterotoxin adjuvant induces long-term protective immunity with reduced levels of immunoglobulin E antibodies.

Authors:  Fumiki Momoi; Tomomi Hashizume; Tomoko Kurita-Ochiai; Yoshikazu Yuki; Hiroshi Kiyono; Masafumi Yamamoto
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

Review 3.  Applications of thiol-disulfide oxidoreductases for optimized in vivo production of functionally active proteins in Bacillus.

Authors:  Thijs R H M Kouwen; Jan Maarten van Dijl
Journal:  Appl Microbiol Biotechnol       Date:  2009-11       Impact factor: 4.813

4.  Draft Genome Sequence of Brevibacillus choshinensis HPD52T (DSM 8552), a Bacterial Host for Efficient Expression of Heterologous Proteins.

Authors:  Jie-Ping Wang; Bo Liu; Guo-Hong Liu; Jian-Mei Che; Zheng Chen; Meichun Chen; Huai Shi
Journal:  Genome Announc       Date:  2016-02-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.